Tempest Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Tempest Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2015 to Q1 2024.
  • Tempest Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $450K, a 923% increase year-over-year.
  • Tempest Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $35.6M, a 212% increase from 2022.
  • Tempest Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $11.4M, a 80.7% decline from 2021.
  • Tempest Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $59.1M, a 70.7% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $450K +$406K +923% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $44K -$1.36M -96.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $1.4M -$13.5M -90.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $14.9M +$9.36M +167% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $5.59M +$5.65M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 -$60K -$17K -39.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 -$43K -$43K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q1 2017 $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q1 2016 $0 -$125M -100% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 $125M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.